Status:
COMPLETED
Short Duration Versus Fourteen Days Antibiotic in Common Bile Duct Cholangitis
Lead Sponsor:
Prince of Songkla University
Conditions:
Acute Cholangitis
Common Bile Duct Calculi
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Common bile duct stone cholangitis is a potentially fatal condition, characterized by an obstruction and bacterial infection of biliary system. The principles of management are appropriate biliary dra...
Detailed Description
The aim is comparing the efficacy and safety between short duration and standard fourteen days antibiotic treatment in patients with acute common bile duct stone (CBDS) cholangitis after successful en...
Eligibility Criteria
Inclusion
- age ≥ 18 years old
- diagnosis of acute mild to moderate severity of ascending common bile duct stone cholangitis
- endoscopic retrograde cholangiopancreatography (ERCP) with biliary drainage within 72 hours after admission
Exclusion
- pregnant woman
- the cause of obstruction other than common bile duct stone
- severe co-morbid diseases such as cardiovascular/pulmonary/kidney disease
- active concomitant infections of other organs
- history of allergy to cephalosporin group
Key Trial Info
Start Date :
August 13 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2019
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT03422042
Start Date
August 13 2017
End Date
August 30 2019
Last Update
March 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NKC Institue of Gastroenterology and Hepatology, Prince of Songkla University
Hat Yai, Changwat Songkhla, Thailand, 90110